Remedly is a B2B enterprise software startup focused on the health care industry. Founded in 2014, it recently received a $250.00K Series A investment on 03 January 2023 from Newchip Accelerator. This investment marks a significant step for Remedly in advancing its mission to revolutionize health care through innovative enterprise software solutions. The backing of Newchip Accelerator not only provides vital funding but also validates Remedly's potential to disrupt the health care technology landscape. With this investment, Remedly aims to further develop its products and expand its reach within the health care sector, positioning itself as a key player in the B2B enterprise software space.
General Information
Get notified when Remedly moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Remedly
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
About Remedly
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 1 | •••• •••• | 03 Jan 2023 |
| Venture Round | •••••• | - | 20 Oct 2020 | |
| Series A | •••••• | 3 |
|
18 Jul 2018 |
| Seed Round | •••••• | 2 |
|
10 Mar 2017 |
| Convertible Note | •••••• | 1 | •••• •••• | 30 Sep 2015 |
Remedly Alternatives & Competitors
Curve is the #1 cloud-based, all-in-one practice management software for 80,000+ dental professional...
FAQ About Remedly
Don't just browse. Track.
Signal Tracker monitors Remedly and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.